Search - tctmd.com

Displaying 521 - 540 of 1207

Sort: Relevancy | Date

Presentation TCT 2018

EFS Experiences Grom the Industry Client Perspective: Whats Good and What Needs to Change?

Presenter: Andrew Farb, Martin B. Leon, Donald E. Bobo Jr

September 22, 2018

Presentation TCT 2018

EFS Decisions: Start-up Company Considerations

Presenter: Andrew Farb, Martin B. Leon, Beverly A Huss

September 22, 2018

News Conference News TCT 2018

TALENT: Indian-Made Supraflex DES Stands Up Well Against Xience in All-Comers

Todd Neale

September 22, 2018

Presentation TCT 2018

Promoting Medical Device Innovation: MDIC Perspectives

Presenter: Andrew Farb, Martin B. Leon, Liz McDermott

September 22, 2018

Presentation TCT 2018

The Second-Generation Cardiovascular EFS Pilot: Progress Report

Presenter: Andrew Farb, Martin B. Leon, David R. Holmes Jr.

September 22, 2018

Presentation TCT 2018

The US EFS Program: FDA Update

Presenter: Andrew Farb, Martin B. Leon

September 22, 2018

Presentation TCT 2018

Industry Perspective

Presenter: C. Michael Gibson, William H. Maisel, Campbell Rogers

September 22, 2018

Presentation TCT 2018

Clinician Scientist/Trialist Perspective

Presenter: C. Michael Gibson, William H. Maisel, James K. Min

September 22, 2018

Presentation TCT 2018

FDA Perspectives

Presenter: C. Michael Gibson, William H. Maisel, Mohua Choudhury

September 22, 2018

Presentation TCT 2018

Keynote Lecture: The Potential Impact of Machine Learning/Artificial Intelligence on Cardiovascular Medical Device Development

Presenter: C. Michael Gibson, William H. Maisel, Peter J. Fitzgerald

September 22, 2018

Presentation TCT 2018

CMS Perspectives

Presenter: Lori M Ashby

September 22, 2018

Presentation TCT 2018

Clinician Perspectives

Presenter: Megan Coylewright

September 22, 2018

Presentation TCT 2018

Patient-Centered Engagement in Trials: Case Example - ADAPTABLE

Presenter: John C Laschinger, J. Dawn Abbott, Lori M Ashby, Robert A. Byrne, David A. Cox, Mona Fiuzat, Christopher O'Connor, John A. Spertus, Susan Strong

September 22, 2018

Presentation TCT 2018

FDAs Patient Engagement Initiatives: How FDA Can Incorporate Patient Centered and Patient Reported Outcomes in Regulatory Decision-Making

Presenter: John C Laschinger

September 22, 2018

Presentation TCT 2018

Keynote Lecture: FDA/CDRH - The Year in Review

Presenter: Mitchell W. Krucoff, Gregg W. Stone, William H. Maisel

September 22, 2018

Presentation TCT 2018

The TCT FDA Town Hall Meetings in Perspective: A Multidisciplinary Collaborative Venture

Presenter: Mitchell W. Krucoff, Gregg W. Stone, Martin B. Leon

September 22, 2018

Presentation TCT 2018

How We Can Utilize the RWE for Regulatory Decision Making? FDA Perspective

Presenter: Neal Fearnot, John C Laschinger

September 22, 2018

Presentation TCT 2018

Seeking a More Effective Way of Utilizing Big Data From Daily Practice in Japan

Presenter: Neal Fearnot, John C Laschinger, Tetsuya Amano

September 22, 2018

Presentation TCT 2018

The Effort of Generating Robust RWE From US Industry

Presenter: Neal Fearnot, John C Laschinger, Theodore Heise

September 22, 2018

Presentation TCT 2018

The Current Situation and Perspective in Japan and International Activity ~CIN, IMDRF~

Presenter: Neal Fearnot, John C Laschinger, Koji Mineta

September 22, 2018

Advertisement

EFS Experiences Grom the Industry Client Perspective: Whats Good and What Needs to Change?

EFS Decisions: Start-up Company Considerations

TALENT: Indian-Made Supraflex DES Stands Up Well Against Xience in All-Comers

Promoting Medical Device Innovation: MDIC Perspectives

The Second-Generation Cardiovascular EFS Pilot: Progress Report

The US EFS Program: FDA Update

Industry Perspective

Clinician Scientist/Trialist Perspective

FDA Perspectives

Keynote Lecture: The Potential Impact of Machine Learning/Artificial Intelligence on Cardiovascular Medical Device Development

CMS Perspectives

Clinician Perspectives

Patient-Centered Engagement in Trials: Case Example - ADAPTABLE

FDAs Patient Engagement Initiatives: How FDA Can Incorporate Patient Centered and Patient Reported Outcomes in Regulatory Decision-Making

Keynote Lecture: FDA/CDRH - The Year in Review

The TCT FDA Town Hall Meetings in Perspective: A Multidisciplinary Collaborative Venture

How We Can Utilize the RWE for Regulatory Decision Making? FDA Perspective

Seeking a More Effective Way of Utilizing Big Data From Daily Practice in Japan

The Effort of Generating Robust RWE From US Industry

The Current Situation and Perspective in Japan and International Activity ~CIN, IMDRF~

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content